🇺🇸 FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11254667

Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11160859

Materials and methods for respiratory disease control in canines

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11154608

Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominan

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11136372

ApoC-II mimetic peptides

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11078239

Prefusion PIV F immunogens and their use

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11052057

Use of cysteamine and derivatives thereof to suppress tumor metastases

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11041008

Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11026947

ALK2 inhibitors and methods for inhibiting BMP signaling

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10934360

Human monoclonal antibodies against EPHA4 and their use

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10898565

Compositions, methods and uses for dengue virus serotype-4 constructs

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10894816

Use of IL-15 to increase thymic output and to treat lymphopenia

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10849970

Antibody evolution immunogens

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10828364

Method for reducing a myeloid derived suppressor cell population with cationic lipid vacci

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10822608

Oligonucleotide analogues targeting human LMNA

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10767184

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10695414

Modulation of replicative fitness by deoptimization of synonymous codons

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10683363

Targeting intracellular target-binding determinants with intracellular antibodies

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10640771

Compositions and methods for treating and preventing macular degeneration

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10584355

Chimpanzee adenoviral vector-based filovirus vaccines

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10568956

Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominan

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10538749

Mutant OPAA enzymes with increased catalytic efficiency on cyclosarin

The United States of America as represented by the Secretary of the Army · Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10538590

Photosensitizing antibody-fluorophore conjugates

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10507187

Regenerative tissue grafts and methods of making same

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10494435

Human monoclonal antibodies specific for CD22

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted